TB-500 (Thymosin Beta-4)

$100.00

99% Pure | USA Made | Multi Dose

TB500 (Thymosin Beta-4) is a synthetic 43-amino-acid peptide fragment used in preclinical models to explore tissue repaircell migration, and inflammation resolution. In cell-culture wound-closure assays and rodent injury models, TB-500 accelerates fibroblast migration, modulates cytokine profiles, and supports angiogenic signaling. Each 10 mg vial is USA-manufactured, HPLC-verified to ≥ 99% purity, endotoxin-screened (< 0.1 EU/mg), and formulated for laboratory research.

What is TB-500?

TB-500, also called TB500 or Thymosin Beta-4 peptide, is a synthetic fragment of the naturally occurring Thymosin β4 protein. It plays a key role in actin-binding, cell-migration, and repair signaling. In research contexts, TB-500 is applied to both in vitro and in vivo models to dissect pathways of tissue regeneration, angiogenesis, and inflammation resolution.

Why Choose TB-500 Peptide?

Researchers select TB-500 when they need a versatile tool for modeling wound healing, vascular growth, and anti-inflammatory effects in controlled experiments. Its proven effect in accelerating cell migration and promoting capillary formation—coupled with strict ISO-certified manufacturing and ≥ 99% purity—ensures reproducible, high-quality data for regenerative-medicine and tissue-repair studies.

What Sets TB-500 Apart?

Unlike broader growth-factor agents, TB-500 peptide offers precise modulation of both cytoskeletal dynamics and angiogenic signaling via its actin-binding properties. Its dual action on cell migration and inflammation resolution, plus demonstrated stability in solution, makes TB-500 the go-to peptide for high-resolution studies of tissue repair and regenerative pathways.

FAQS

TB500 is a synthetic Thymosin Beta-4 fragment used to study wound healing, cell migration, and angiogenesis.

TB500 is a synthetic peptide fragment of the full Thymosin β4 protein, designed for research applications.

By enhancing fibroblast and keratinocyte migration and upregulating VEGF, TB-500 speeds gap closure and blood-vessel growth.

Yes. TB-4 is often co-studied with peptides like BPC-157, GHK-Cu, or growth factors to assess synergistic effects on repair.

Yes—TB-500 downregulates IL-6 and TNF-α in macrophage models, aiding inflammation-resolution research.

Lyophilized TB-4 should be stored at –20 °C; reconstituted solutions are best kept at 2–8 °C and used within 7 days.

Yes. Preclinical studies show TB-4 enhances VEGF expression and capillary network formation in endothelial assays.

TB-4 modulates IL-6 and TNF-α levels in macrophage cultures, offering a research tool for inflammation-resolution studies.

Is TB-4 approved for therapeutic use?

Real Peptides offers ISO-certified, USA-made TB-500 (10 mg) at ≥ 99% purity and low endotoxin—available for research use only.

Related Products